Skin absorption of the industrial catalyst dimethylethylamine in vitro in guinea pig and human skin, and of gaseous dimethylethylamine in human volunteers

International Archives of Occupational and Environmental Health

Volumn 70, Issue 5, 1997, Pages 309-313

  Lundh, Thomas ^a,c   Boman, Anders ^b   Åkesson, Bengt ^a  

^a LUND UNIVERSITY   (Sweden)

^b NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biological monitoring; Dimethylethylamine; Permeability coeffcient; Steady state flux; Uptake

Indexed keywords

ALIPHATIC AMINE; DIMETHYLETHYLAMINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BIOLOGICAL MONITORING; CATALYST; FOREARM; GAS CHROMATOGRAPHY; GAS DIFFUSION; GUINEA PIG; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NONHUMAN; NORMAL HUMAN; OCCUPATIONAL HAZARD; PERMEABILITY; SKIN ABSORPTION; URINALYSIS;

ADULT; ANIMALS; ENVIRONMENTAL MONITORING; ETHYLAMINES; GUINEA PIGS; HUMANS; INHALATION EXPOSURE; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PERMEABILITY; SKIN ABSORPTION;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA; TRIXIS;

EID: 0030670750     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004200050223     Document Type: Article

References (23)

1. Albrecht WN, Stephenson RL (1988) Health hazards of tertiary amine catalysts. Scand J Work Environ Health 14: 202-219
2. Andersen KE, Maibach HI, Anjo MD (1980) The guinea-pig: an animal model for human skin adsorption of hydrocortisone, testosterone and benzoic acid. Br J Dermatol 102: 447-453
3. Barry BW (1986) Penetration enhancers. In: Shroot B, Schaefer H (eds) Skin pharmacokinetics. Pharmacology and the skin 1. Karger, Basel, pp 121-127
4. Bronaugh RL (1991) A flow-through diffusion cell. In: Bronaugh RL, Maibach HI (eds) In vitro percutaneous absorption: principles, fundamentals, and application. CRC Press, Boca Raton, pp 17-23
5. Dubois D, Dubois EF (1916) Clinical calometry, tenth paper. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17: 863-872
6. Elias PM, Feingold KR, Menon GK, Grayson S; Williams ML, Grubauer G (1987) The stratum corneum two-compartment model and its functional implications. In: Shroot B, Schaefer H (eds) Skin pharmacokinetics. Pharmacology and the skin 1. Karger, Basel, pp 1-9
7. Grandjean P (1990) Skin penetration: Hazardous chemicals at work. Taylor and Francis, London, pp 3-34
8. Johansson G, Fernström P (1988) Influence of water on the percutaneous absorption of 2-butoxiethanol in guinea pigs. Scand J Work Environ Health 14: 95-100
9. Johansson G, Boman A, Dysesius B (1988) Percutaneous absorption of 2-butoxiethanol in man. Scand J Work Environ Health 14: 101-119
10. Johansson G, Boman A (1991) Percutaneous absorption of 2-butoxiethanol vapour in human subjects. Br J Ind Med 48: 788-792
11. Lowe NJ, DP Meyer, Wieder JM, Luftman D, Borget T, Lehman MD, Johnson AW, Scott IR (1995) Low doses of repetitive ultraviolet A induce morphologic changes in human skin. J Invest Dermatol 105: 739-743
12. Lundh T, Ståhlbom B, Åkesson B (1991a) Dimethylethylamine in mould core manufacturing: exposure, metabolism, and biological monitoring. Br J Ind Med 48: 203-207
13. Lundh T, Ståhlbom B, Åkesson B (1991b) Methods for the determination of dimethylethylamine and dimethylethyl-N-oxide in air, plasma and urine samples. Int J Environ Anal Chem 44: 81-86
14. Lundh T, Åkesson B, Skerfving S (1995) Effect of dietary intake of trimethylamine on human metabolism of the industrial catalyst dimethylethylamine. Occup Environ Med 52: 478-483
15. McDougal JN, Jepson GV, Clewell HJI, Gargas ML, Andersen ME (1990) Dermal absorption of organic vapours in rats and humans. Fundam Appl Toxicol 14: 299-308
16. Melsky JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL and 28 participating investigators (1977) Oral methoxsalen photochemotherapy for the treatment of psoriasis: A cooperative clinical trial. J Invest Dermatol 68: 328-335
17. Riihimäki V, Pfäffli P (1978) Percutaneous absorption of solvent vapours in man. Scand J Work Environ Health 4: 73-85
18. Siddiqui O (1989) Physicochemical, physiological, and mathematical considerations in optimizing percutaneous absorption of drugs. Crit Rev Ther Drug Carrier Syst 6: 1-38
19. Ståhlbom B, Lundh T, Florén I, Åkesson B (1991a) Visual disturbances in humans at experimental and occupational exposure to dimethylethylamine. Br J Ind Med 48: 26-29
20. Ståhlbom B, Lundh T, Åkesson B (1991b) Experimental study on the metabolism of dimethylethylamine in man. Int Arch Occup Environ Health 63: 305-310
21. SNBOSH (1993) Occupational exposure limits. Swedish National Board of Occupational Safety and Health. Hygieniska gränsvärden [Threshold limit values] (AFS 1996:2) (in Swedish) Liber, Stockholm
22. Wallace AB (1951) The exposure treatment of burns. Lancet I: 501-504
23. Wester RC, Maibach HI (1991) In vivo percutaneous absorption. In: Marzulli FN, Maibach HI (eds). Dermatotoxicology, 4th edn. Hemisphere, New York, pp 75-96